Preview Mode Links will not work in preview mode

Oct 29, 2007

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Blaise Bourgeois & Dr. Nathan Fountain interview Dr. Samuel Berkovic from the Epilepsy Research Center University of Melbourne, Australia about his paper studying the use of levetiracetam in patients with idiopathic generalized epilepsy. The podcast concludes with Dr. Andrew Tarulli interviewing Dr. Michael J. Lynn for the Lesson of the Week. Podcast participants had nothing to disclose except for Drs. Berkovic and Bourgeois. Dr. Berkovic has received grants in excess of $10,000 and honoraria not in excess of $10,000 from UCB Pharma SA, who were involved in the design and conduct of the study; collection, management, and analysis of the data; and preparation and review of the manuscript. Dr. Bourgeois has received grant support or consulting fees from Abbott, Eisai, Elan Pharmaceuticals, Ortho-McNeil, Novartis, Ovation Pharma, and UCB Pharma in excess of $10,000.The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.